A carregar...
Neuroprotective therapies for glaucoma
Glaucoma is the second leading cause for blindness worldwide. It is mainly caused by glaucomatous optic neuropathy (GON) characterized by retinal ganglion cell loss, which leads to visual field defect and blindness. Up to now, the main purpose of antiglaucomatous therapies has been to lower intraocu...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4362661/ https://ncbi.nlm.nih.gov/pubmed/25792807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S80594 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|